The immunized animals showed decreased CD4 + FoxP3 + T cells, increased interferon (IFN)-γ and IL-17a levels, enhanced KRAS-specific Th1 and Th17 responses, and significantly reduced tumor incidence compared to controls [124]. The gene discussed is CD4; the disease is neoplasm.